KLRS- Kalaris Therapeutics, Inc.

Name: Kalaris Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Kalaris Therapeutics, Inc. (KLRS) has 2 insiders with recent SEC Form 4 filings, including 1 buy and 11 sells. KLRS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Akkaraju Srinivas	2.22M	$9.79M	-
CFO	Gall Matthew	235.0K	$1.03M	-

Activity

Buys and sells only

Transactions

10 filings · page 14

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 17, 2022	Van Beek Jeroen B85	Chief Commercial Officer	Sell	15,262	$4.40	$67,166.54	-3.8%	+86.3%	-9.8%
Apr 26, 2022	Bornstein Jeffrey S	Director	Buy	5,000	$4.64	$23,196.50	+14.2%	-1.5%	-25.3%
Apr 21, 2022	Hallal David79	Director, 10% Owner	Sell	4,227	$5.87	$24,812.49	-0.2%	-1.7%	-29.0%
Apr 21, 2022	Atillasoy Ercem78	See Remarks	Sell	2,040	$6.04	$12,328.60	-0.8%	-1.7%	-29.0%
Apr 20, 2022	Sinha Vikas84	See Remarks	Sell	1,162	$6.68	$7,767.16	-0.1%	-17.9%	-39.5%
Apr 20, 2022	Van Beek Jeroen B85	Chief Commercial Officer	Sell	852	$6.68	$5,695.02	-0.2%	-17.9%	-39.5%
Apr 20, 2022	Hagen Brett R84	Chief Accounting Officer	Sell	276	$6.68	$1,844.87	-0.3%	-17.9%	-39.5%
Mar 11, 2022	Hallal David79	Director, 10% Owner	Sell	65,725	$7.48	$491,849.80	-1.5%	-45.4%	-33.7%
Mar 2, 2022	Van Beek Jeroen B85	Chief Commercial Officer	Sell	516	$9.01	$4,651.38	-0.1%	-56.9%	-32.6%
Feb 16, 2022	Van Beek Jeroen B85	Chief Commercial Officer	Sell	15,322	$8.32	$127,525.01	-3.8%	-46.2%	-27.7%

← PrevPage 14Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC